Exact Sciences Corp. (EXAS) Social Stream

Featured Post From StockTwits About EXAS

$EXAS

Exact will be the first company that successfully develops and commercializes liquid biopsy screening. My bet. I do like other companies working toward this including GH and ILMN. Own ILMN too in decent size for 5 years. EXAS for 7 years.

This is not easy, but will be disruptive science. We will and should move away from expensive and invasive screening tests as time moves forward. It is a matter of when.

Conroy is a patent attorney who understands process deeply. For those new here, were you aware that Cologuard was approved by the FDA and CMS at the same time? Pretty impressive.